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Figure 1 A schematic flow of creating three-dimensional
(3D) printed products.
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Over the past 30 years, there has been great advancement
in medical technologies. Three-dimensional (3D) printing, a
technique based on topography and photosculpture, was
originally developed in 1986 by Charles W. Hull to build
objects layer by layer based on digital drawings [1,2]. This
technique, also known as additive manufacturing, was
designed to shorten the design cycle of new products by
fabricating plastic prototypes (rapid prototyping). Different
kinds of materials, such as metals and ceramics, can be
used for the printing of 3D objects. By using digital blue-
prints and image data, 3D printing has been used in various
applications, such as manufacturing, the food industry,
education, and art. For example, using the front and side
view photographs of a person, customised prescription
glasses can be 3D printed to fit personal facial features [3].
In orthodontics, x-ray images and photographs of patient’s
teeth can be taken or scanned using a 3D scanner. These
digital images are used for treatment plans and printing
orthodontics braces to align teeth [4].
The ability to use medical image data for designing a
model has opened up new possibilities in the field of
medicine. Three-dimensional printing can be used for
patient-specific therapy, as it allows for the fabrication of
custom-made implants and medical devices. In parallel,
with the concept of personalised medicine, which refers to
patient-specific medication based on patients’ genetic
profile, 3D printing can be used for personalised treatment.
In the past few years, there has been an increase in the
number of publications describing the use of 3D printing
techniques in patient-specific treatments. Further research
in tissue engineering and regenerative medicine focus on
developing specific printers and materials to create 3D
constructs with living cells, growth factors, and other
biomaterials using 3D printing [5]. These constructs are
envisioned to replace damaged or diseased tissues and can
also be used as a disease or toxicity model to study the
interaction between different cell types or for drug
screening. This fabrication process, also known as bio-
fabrication, which involves the printing of living cells and
biomaterials, is defined as: “the automated generation of
biologically functional products with structural organisa-
tion from living cells, bioactive molecules, biomaterials,
cell aggregates such as microtissues, or hybrid cell-
material constructs, through bioprinting or bioassembly
and subsequent tissue maturation processes” [6]. It offers
the possibility to build complex tissues by the deposition of
various bio-inks, such that the form and content of a
construct can be tailored to the tissue to be repaired. In
this article, the current techniques and recent de-
velopments of 3D printing, for orthopaedic applications in
particular, is presented.
Current technologies
The general workflow of creating a 3D printed product
consists of a number of subsequent steps: (1) imaging and
data processing; (2) selection of printing techniques; (3)
selection of materials and bioactive components; and (4)
printing/bioprinting of products (Figure 1).Imaging and data processing
Combining medical imaging and 3D printing opens up new
possibilities for patient-specific therapy, as it allows for
the customisation of prosthetics and implants and visual-
isation of complicated pathologies. The process of creating
3D models from imaging data involves image acquisition,
data segmentation, and transformation into digital 3D
models, followed by 3D printing and post processing [7].
The choice of imaging technique is based on the intended
application and image resolution. The resolution of the
resulting image is important, as images with poor resolu-
tion will result in an inaccurate and unfit model. In or-
thopaedics, imaging techniques such as x-ray imaging,
computed tomography (CT), and magnetic resonance im-
aging (MRI) are commonly used. X-ray imaging and CT are
often employed to diagnose bone fractures or muscle dis-
orders, whereas MRI is used to detect soft tissue damage.
Once the initial imaging data has been acquired, further
processing, which includes selecting and isolating the re-
gion of interest using open or proprietary software, and
transforming segmented data into volumetric data, will be
carried out prior to printing.Printing techniques
In order to meet the intended applications of a scaffold or
implant, the architectural design of a construct at various
levels, macro- (overall shape), micro- (tissue architecture)
and nano-scales (surface modification) is important [8]. The
selection of a 3D printer depends highly on the materials of
interest and resolution of the products. Common printing
techniques include fused deposition modelling (FDM), se-
lective laser sintering (SLS), and inkjet printing. FDM
printers generally extrude materials that are heated at the
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head moves, it builds objects in thin layers. This cycle of
printing repeats until a solid 3D object forms. SLS uses a
laser as an energy source and draws the shape of an object
to sinter powdered material. A new layer of material ap-
plies on top, and the process repeats until the part is
completed. Inkjet printing uses thermal, air pressure,
electromagnetic, or piezoelectric technology to dispense
droplets of ink onto a substrate. By changing the applied
temperature gradient, pressure, pulse frequency, and ink
viscosity, the droplet size can be modified for different
applications. Based on the versatility, precision and speed
of the printers, and the availability of materials, these
printing techniques have been used to print objects for
different applications.
Materials
Each material for 3D printing has its specific mechanical
properties, processing methods, chemical properties, and
cell-material interactions. Some of the commonly used
materials include metals, bioceramics, synthetic, and
natural polymers (Figure 2). Metals and bioceramics are
mainly employed to create implants and for bone resto-
ration. For implantation, titanium (Ti) and its alloys have
been demonstrated to be biocompatible with good me-
chanical properties [9]. Bioceramics, such as hydroxyapa-
tite (HA), calcium phosphate, and bioglass, have been used
for bone regeneration, as they are osteogenic, porous,
maintain their shape, and promote cell proliferation on
their surfaces. However, these materials lack appropriate
mechanical strength for implantation in load-bearing sites
[10,11]. Recently, scaffolds based on composite materials,
such as HA and tricalcium phosphate (TCP) [12e14], poly-
caprolactone (PCL)-HA with carbon nanotubes [15], PCL-
poly lactic-co-glycolic acid (PLGA) [16e19], and PLGA-
TCP [20e22] have been investigated as scaffold materials
in order to optimize the architecture, biocompatibility,
and sintering conditions (particle size and sinteringFigure 2 Materials commonly used in three-temperature) to improve the porosity, mechanical
strengths, and biocompatibility of these constructs.
Hydrogels, another important class of biomaterials, are
commonly used as cell carriers in tissue engineering.
Hydrogels are designed to act as an artificial extracellular
matrix and provide living cells a 3D environment to grow.
The combination of hydrogel with cells and/or growth
factors functions as a bio-ink. The type of polymer,
chemical composition, molecular weight, and concentra-
tion of hydrogel directly determines the viscosity, speed of
gelation, and mechanical strength of the scaffold.
The optimal printing fidelity (shape, complexity, and
resolution of the construct) will be determined by the
processing parameters, including the fabrication time and
nozzle gauge, which in turn, will affect the cell viability
and function [5]. Therefore, materials should be carefully
chosen based on the intended application of the construct.
Aspects, such as the mechanical strength of the materials
and structural requirements of the constructs are essential,
as these vary among the diverse target tissues. The ulti-
mate goal is to mimic the structure and mechanical prop-
erties of the native/target tissue and develop the printed
constructs into a functional tissue. However, the lack of
printable and regulatory bodies approved materials, suit-
able bio-inks, and lengthy production time limits the
development of bioprinting for clinical use. Therefore, the
current development of materials for bioprinting aims to
solve these problems.Current applications in orthopaedics
Three-dimensional printing offers a range of possibilities
for patient-specific therapy. In orthopaedics, 3D printing
has been applied in various aspects including designing and
printing customised equipment for surgery, printing im-
plants, and prostheses for support, and regenerating
musculoskeletal tissues including bone, cartilage, and soft
tissues such as tendon, ligament, and muscles.dimensional (3D) printing and bioprinting.
3D printing for orthopaedic applications 45Customised surgical assistive tools and implants
Three-dimensional printing is a suitable technique to create
patient-specific anatomical models, customised moulds,
and surgical guides, as well as permanent implants. Some of
the many benefits of employing 3D printing are that it al-
lows better surgical planning, creates customised patient-
specific implants, shortens surgical time, and hospital stay.
It also reduces morbidity, yields better fitting of prosthesis,
as well as better educates and enhances patients’ under-
standing of surgical procedures. Many of the patient-
specific models, guides, and templates are routinely used
(Figure 3). For example, patient-specific 3D printed screw
guide template systems can benefit intraoperative pedicle
screw fixation, a standard procedure of spinal instrumen-
tation, in the thoracic spine by improving the accuracy of
the surgical procedure, reducing the operating time and
radiation exposure during the surgery [23]. Furthermore,
patient-specific, disposable surgical saw guides/cutting-
blocks can be printed for the use in total knee arthro-
plasty. The use of imaging and planning software, the
different cuts of the bone resections, and the size and
position of the knee implant can be planned prior to sur-
gery. Each patient-specific saw guide/cutting-block pro-
vides guidance to surgeons during surgery, and reduces the
number of decisions he/she has to make during surgery.
This can minimize tissue loss and optimise the positioning of
implants, and hence, lengthen the lifetime of the pros-
thetics [24]. With the use of patient-specific surgical as-
sistive tools, the risk of surgical errors and outliers can beFigure 3 (A) Patient-specific sawguides for total knee arthropla
acetabulum implant with screw planning (Materialise, Belgium).reduced, and operations will be less dependent on the
experience of the physician.
In addition to surgical assistive tools, implants have also
been printed for treating orthopaedic diseases. For
example, a 3D printed customised axial vertebral body has
recently been implanted in the upper cervical spine of a
patient [25]. One case study has also employed 3D printing
to create a titanium calcaneal prosthesis for a patient who
has chondrosarcoma in the heel [26]. These cases demon-
strate how 3D printed, patient-specific implants may bring
individualised solutions to rare and complicated problems,
where restoration of the specific anatomy of each patient
remains challenging.
Musculoskeletal tissues
Three-dimensional printing approaches that aim to solve
various musculoskeletal tissue diseases are currently under
development and are most frequently studied in vitro for
bone and cartilage regeneration, and fewer for meniscus,
tendon, ligament, and muscle regeneration. As 3D bio-
printing has not reached the clinic yet, the following sec-
tions will describe and review the current trends in the
application of 3D printing for musculoskeletal tissue
regeneration.
Bone regeneration
Bone is a dynamic tissue, with the ability to self-regenerate
and self-repair. However, cancer, trauma, infection, and
congenital deformity can lead to massive bone defects orsty (Smith & Nephew, USA) and (B, C) custom-made titanium
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autologous bone grafts (autografts, allografts, and artificial
bone substitutes), which promotes bone healing through
osteogenesis, osteoinduction, and osteoconduction, have
been used for this purpose [27]. However, some of the
major limitations of these grafts include donor site co-
morbidity, rejection, poor graft incorporation, and trans-
mission of disease [28]. Therefore, tissue engineering,
which uses scaffolds and combinations of cells, materials,
and/or biologics to improve or replace biological tissues, is
an attractive strategy for bone regeneration. Some of the
essential elements of an effective bone scaffold include the
use of biocompatible and bioactive materials, and a porous
3D matrix that allows cell attachment, delivery of nutrients
to cells and cell migration, and the ingrowth of blood ves-
sels. In addition, the scaffold must possess a suitable me-
chanical stability, flexibility and allow the transfer and
diffusion of growth and differentiation factors [29]. For cell
viability and tissue maturation within a gel, covalent
immobilisation of extracellular matrix (ECM) molecules or
adhesive peptides can be used. For example, the presence
of a peptide such as arginineeglycineeaspartic acid
significantly increases the amount of bone formation in an
alginate scaffold. In addition, the delivery of multiple
growth factors has also been demonstrated to improve bone
tissue formation in alginate gels [30]. In addition, poly-
ethlyene glycol (PEG) hydrogels have been used extensively
as mechanically strong, cytocompatible matrices, which
can maintain cell viability and promote ECM production
[31e33]. Because 3D printing allows a precise control of the
overall geometry and the internal porous structure of a
scaffold, much of the current research on bone regenera-
tive medicine utilises this versatile technique. One recent
publication studied the biocompatibility of 3D printed
calcined boneebiphasic ceramic composite/PVA gel both
in vitro and in vivo. The scaffold showed good mechanical
properties, and the rabbit’s bone marrow stromal cells
grew, proliferated, and differentiated on the surface of the
scaffold after adherence. In vivo experiments also
demonstrated that the bone scaffolds showed high
biocompatibility [34]. One study introduced osteoinductive
compounds, silica (SiO2), and zinc oxide (ZnO), to b-TCP, a
known osteoconductive material, and were 3D printed to
investigate their osteoinduction potential in vivo. The re-
sults of this study showed that the combination of SiO2 and
ZnO dopants in TCP maybe a viable alternative to introduce
osteoinductive properties to calcium phosphates (CaPs)
[35]. Other novel approaches in bioprinting combined
human mesenchymal stem cells (hMSCs) and poly(ethylene)
glycol dimethacrylate (PEGDMA) with bioactive glass and/or
HA to form the homogeneous bone constructs in a layer-by-
layer approach. Significantly higher total collagen produc-
tion and alkaline phosphatase (ALP) activity in hMSCs were
observed within the printed scaffold. This higher collagen
production was also observed in previous studies, and the
presence of HA increased the ALP activity in hMSCs and
promoted osteogenesis [36,37]. Future research directions
include exploring and expanding the current group of bio-
materials for bone regeneration, as well as studying the
stability of the individually designed blocks, potentially
with incorporated prevascular networks for larger bone
replacement without an external matrix for support.Cartilage regeneration
Cartilage degeneration due to age or injuries is one of the
most common musculoskeletal problems. Articular carti-
lage, which lines all the articular joints in the body, pro-
vides a smooth, lubricated surface and mechanical support
of joint movements [38]. The articular cartilage, a hyaline
cartilage, has a unique composition and is comprised of an
extracellular matrix composed of water, collagen, pro-
teoglycans, noncollagenous proteins and glycoproteins, and
highly specialized chondrocytes which contribute to four
zones of cartilage, the superficial, middle, deep, and
calcified zone [38]. The articular cartilage is avascular,
lacks innervation and a lymphatic system, and is subjected
to a harsh biochemical environment in the intra-articular
space. With the absence of blood flow, the articular carti-
lage has a limited capacity for intrinsic healing and repair.
Very often, untreated cartilage injuries will progress to
arthritis of the joint, which currently has no cure. Bio-
printing can create constructs, which mimics the archi-
tecture of tissues to be repaired, and provides a potential
treatment modality for cartilage repair [39]. Besides, the
size, depth, and strength of the construct can be monitored
closely. Before the implantation of the tissue into the body,
the bioprinted construct needs to grow in a controlled
environment (bioreactor) into a functional tissue. The
maturation will then take place in vivo and the construct/
tissue can integrate into the host body/tissue. Another
possibility would be to integrate the functions of the tissue
directly into the printed construct. For example, one study
has investigated the fabrication of cell-laden, heteroge-
neous hydrogel constructs using 3D printing for the poten-
tial use as osteochondral grafts. Both osteogenic
progenitors and chondrocytes were encapsulated in
different parts of the construct, and the study demon-
strated that the anticipated tissue type were formed [40].
A similar study attempted to build osteochondral constructs
using two different materials, PCL and alginate, and
encapsulate with osteoblasts and chondrocytes. This study
was able to create a dual cell-laden scaffold, with
enhanced mechanical properties while maintaining the
anatomical position and viability of cells [41].
The current development of bioprinting of cartilage
tissue constructs includes improving the mechanical
strength of hydrogels by coupling with synthetic polymers,
creating zone specific cartilage constructs and creating
osteochondral plugs that include both the cartilage and
bone compartments [42]. For example, PCL fibres and
chondrocytes suspended in a fibrinecollagen hydrogel have
been printed to create a cartilage construct. The study
demonstrated that the constructs formed cartilage-like
tissues both in vitro and in vivo, and with enhanced me-
chanical properties [43]. To create zone specific cartilage,
multilayered constructs composed of various combinations
of polymers, including PEG, hyaluronic acid, chondroitin
sulphate, and metalloprotease sensitive peptides were
used to encapsulate a single lineage of mesenchymal stem
cells. The study was able to create a single construct, which
comprised of all three zones of articular cartilage from one
single stem cell lineage [44].
One of the obstacles of using the current biomaterials
for cartilage repair is that there is limited cell-material
interactions and often forms inferior tissues [45]. Besides,
3D printing for orthopaedic applications 47the available synthetic or natural biomaterials are unable
to mimic the complexity of natural extracellular matrix and
its intrinsic functions. Recently, decellularised ECM (dECM)
has been printed to provide microenvironments that induce
the growth of cartilage tissue. This study demonstrated
that dECM provides crucial signals for cells engraftment,
survival and its long-term function [45]. Therefore, in order
to create constructs for optimal cartilage regeneration, the
mechanical strength, cell survival, and functionality are
equally important.
Meniscus regeneration
Meniscus in the knee is a fibrocartilaginous tissue, which
acts as a shock absorber to protect the articular cartilage
during knee movements and stabilize the knee. Similar to
articular cartilage, the meniscus has a heterogeneous
composition of connective tissue cells including the
fibroblast-like cells, fibrochondrocytes and chondrocyte-
like cells, and components such as collagen type I, II, and
glycosaminoglycans [46]. The meniscus also has minimal
blood flow; the central region is avascular and therefore,
fails to heal. The current surgical treatments for meniscal
injuries include total and partial meniscectomy, meniscal
repair, and meniscal transplantation. Meniscus allografts
have been demonstrated to provide short-term benefits in
young patients, however, the durability and ability to
reduce the risk of progression of osteoarthritis of these
allograft is still unknown.
Tissue-engineering approaches have been investigated
for meniscus regeneration. Previous work on meniscus
regeneration aimed to mimic the structure, mechanical
properties, and improve the integration of meniscal scaf-
folds using various combinations of biomaterials and cells.
For example, scaffolds, made of polyurethane, showed
optimal mechanical properties with interconnective macro-
porosity to facilitate cell ingrowth and differentiation [47].
One study utilized a 3D printing technique, projection
stereolithography, to simulate the structural architecture
of meniscus, and the scaffold was seeded with human cells
from the meniscus. This study demonstrated that cells were
able to grow with an organised cellular alignment and
promote meniscus-like tissue formation [48]. In addition,
one recent study was able to mimic the zone-specific ma-
trix phenotypes of meniscus in 3D printed scaffolds incor-
porated with spatiotemporally delivered human connective
tissue growth factor and transforming growth factoreb3.
These implants were placed in sheep, and the regenerated
meniscus demonstrated the ability to restore the mechan-
ical integrity of the meniscus [49].
Tendon, ligament, and muscle regeneration
In addition to bone, cartilage, and meniscus, the muscu-
loskeletal system is also made up of muscles and connective
tissues including tendon and ligament, which are structur-
ally optimised to generate and transfer force, and facilitate
movements. Similar to bone and cartilage, tissue engi-
neering using 3D printing techniques have been employed
to mimic and create functional muscles, tendons, and lig-
aments. Large skeletal muscle tissue defects can be due to
trauma, tumours, and congenital conditions. The current
treatment options are limited by the availability of host
tissues, as well as donor site morbidity. In one study, humanskeletal muscle cells were seeded onto a scaffold, which
was created by electrospinning. The results showed that
the orientation of the nanofibres can significantly affect the
induction of muscle cell alignment and myotube formation,
and that the aligned composite nanofibre is promising for
future functional muscle tissue implantation [50]. Taking
this one step further, researchers have also begun to
investigate fabricating tissues as a functional, composite
unit, for example a muscle-tendon unit and ligament-bone
unit. One study has specifically attempted to create a
region-specific scaffold, using two synthetic polymeric
materials and two cell-laden hydrogel based bioinks, to
mimic the mechanical and biological properties of muscles
and tendons [51]. In addition, an in vivo study employed 3D
printing to create a ligament-bone composite scaffold with
an aim to aid ligament reconstruction surgeries. The
ceramic bone scaffold was created using 3D printed resin
moulds, and the ligament scaffold was created by weaving
degummed silk fibres. The study demonstrated that there
was a significant difference in mechanical strengths, new
bone formation in the bone scaffolds, as well as a gradual
structural transition between the scaffolds and host bones.
This signified that the ligament-bone composite scaffolds
was able to facilitate the regeneration of tissues at the
ligamentebone interface [52].Challenges and future directions in bioprinting
With the ability to further mimic the cellular and extracel-
lular structure and components of a tissues and organs, 3D
printing possesses significant potential in regenerative
medicine. However, there are challenges and limitations in
every step of creating a biological construct, from printing
techniques tomaterials andcell sources. Although significant
steps have been taken, further optimisation of bioinks,
fabrication time, and biological performance would be
necessary in order to bring 3D bioprinting to the clinic. There
is currently a limited range of biomaterials available for
bioprinting, as most publications are using very similar ma-
terials [5]. Therefore, there is a need to investigate and
develop a diverse selection of materials that are biocom-
patible, mechanically supportive and can maintain cell
viability and functions for 3D (bio)printing. In addition,
similar to any organ or tissue transplantation, there is always
a chance of rejection of bioprinted constructs by the host
immune system. Autologous and allogenic (stem) cells and
induced pluripotent stem cells are alternative cell sources;
however, research on their safety will need to be further
verified. Furthermore, the maturation of cells, vasculature
and innervation are commonchallenges for the bioprinting of
larger tissue constructs. Vascularisation is essential for the
long-term viability of cells. A recent review has suggested
using a bioreactor for vascularisation, as it can maintain the
viability of a tissue construct while allowing further pro-
cessing. For example, using bioreactor processing in combi-
nation with factors that promote angiogenesis and
innervation can maintain cell viability [53].
Three-dimensional printed constructs, such as other
medical devices, are subjected to regulatory approval prior
to commercialisation. Currently, 3D printed devices are
subjected to the same regulations listed in Section 510(k) of
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(US) Food and Drug Administration (FDA). However, devices
created by 3D printing may require different or additional
testing, as they go through different manufacturing tech-
niques and consist of various parts such as materials, drugs,
and cells, compared with traditional techniques. Most
printed implants that have been applied in patients were
either used for improving surgical precision, for example, a
3D printed titanium bone tether plate has been granted FDA
clearance to preserve bone anatomy [54], or were granted
emergency use such as 3D printed splints implanted in ba-
bies with severe tracheobronchomalacia [55]. The FDA is
working towards issuing guidance on 3D printing, and a
public workshop on additive manufacturing of medical de-
vices was held in October 2014 to discuss medical consid-
erations of 3D printing [56].
Although 3D printed metal implants, (cell-free)
biocompatible plastic materials and or constructs as car-
riers and custom-made devices are already available in
clinical settings, bioprinting is still in its infancy and far
from clinical applicability. The organised printing of cells
and biomaterials will, in the short term, be primarily used
as a test model in research settings. The challenges and
limitations mentioned are still restricting the clinical im-
plantation of living printed constructs. To obtain a func-
tional 3D printed tissue, the organisation of the printed
construct, the environment for the optimal tissue matura-
tion, and the printing techniques should be further opti-
mised. After overcoming the technical limitations and
proving clinical effectiveness, there will be more applica-
tions of “tissues from the printer”.
Conflicts of interest
The authors have no conflicts of interest relevant to this
article.
Funding/support
The authors would like to acknowledge the Lui Che Woo
Foundation Limited (Hong Kong, China) and the Dutch
Arthritis Foundation (LLP-12; Amsterdam, The Netherlands)
for funding.References
[1] Hull CW. Apparatus for production of three-dimensional ob-
jects by stereolithography U.S. Patent, Editor 1986, UVP, Inc.,
San Gabriel, Calif.: USA.
[2] Bourella D, Beaman Jr J, Leub M, Rosen D. A brief history of
additive manufacturing and the 2009 roadmap for additive
manufacturing: looking back and looking ahead. US-TURKEY
Workshop on Rapid Technologies. 2009 September 24. p. 1e8.
Istanbul, Turkey.
[3] SharmaR. Customeyewear: the next focal point for 3D printing?
Jersey City, NJ, USA. 2013. Available at: http://www.forbes.
com/sites/rakeshsharma/2013/09/10/custom-eyewear-the-
next-focal-point-for-3d-printing/ [accessed 01.12.15].
[4] Bishop A, Womack WR, Derakhshan M. An esthetic and
removable orthodontic treatment option for patients: invis-
align. Dent Assist 2002;71:14e7.[5] Malda J, Visser J, Melchels FP, Jungst T, Hennink WE,
Dhert WJA, et al. 25th anniversary article: engineering
hydrogels for biofabrication. Adv Mater 2013;25:5011e28.
[6] Groll J, Boland T, Blunk T, Burdick JA, Cho DW, Dalton PD,
et al. Biofabrication: reappraising the definition of an evolving
field. Biofabrication 2016;8:013001. http://dx.doi.org/
10.1088/1758-5090/8/1/013001.
[7] Marro A, Bandukwala T, Mak W. Three-dimensional printing
and medical imaging: a review of the methods and applica-
tions. Curr Probl Diagn Radiol 2015;45:2e9.
[8] Chia HN, Wu BM. Recent advances in 3D printing of bio-
materials. J Biol Eng 2015;9:4e18.
[9] Wiria FE, Shyan JYM, Lim PN, Wen FGC, Yeo JF, Cao T. Printing
of Titanium implant prototype. Mater Des 2010;31:101e5.
[10] Thamaraiselvi T, Rajeswari S. Biological evaluation of bio-
ceramic materialsea review. Trends Biomater Artif Organs
2004;18:9e17.
[11] Oh S, Oh N, Appleford M, Ong JL. Bioceramics for tissue en-
gineering applicationsea review. Am J Biochem Biotechnol
2006;2:49e56.
[12] Castilho M, Moseke C, Ewald A, Gbureck U, Groll J, Pires I,
et al. Direct 3D powder printing of biphasic calcium phosphate
scaffolds for substitution of complex bone defects. Bio-
fabrication 2014;6:1e12.
[13] Ishack S, Mediero A, Wilder T, Ricci J, Cronstein B. Bone
regeneration in critical bone defects using three-dimension-
ally printed b-tricalcium phosphate/hydroxyapatite scaffolds
is enhanced by coating scaffolds with either dipyridamole or
BMP-2. J Biomed Mater Res B Appl Biomater 2015. http:
//dx.doi.org/10.1002/jbm.b.33561.
[14] Chen S, Zheng L, Xie X, Wang X, Lai Y, Chen S, et al.
Comparative study of poly (lactic-co-glycolic acid)/tricalcium
phosphate scaffolds incorporated or coated with osteogenic
growth factors for enhancement of bone regeneration. J
Orthop Transl 2014;2:91e104.
[15] Goncalves EM, Oliveira FJ, Silva RF, Neto MA, Fernandes MH,
Amaral M, et al. Three-dimensional printed PCL-hydroxyapa-
tite scaffolds filled with CNTs for bone cell growth stimula-
tion. J Biomed Mater Res B Appl Biomater 2015. http:
//dx.doi.org/10.1002/jbm.b.33432.
[16] Shim JH, Yoon MC, Jeong CM, Jang J, Jeong SI, Cho DW, et al.
Efficacy of rhBMP-2 loaded PCL/PLGA/beta-TCP guided bone
regeneration membrane fabricated by 3D printing technology
for reconstruction of calvaria defects in rabbit. Biomed Mater
2014;9:2e9.
[17] Yang W, Both SK, van Osch GJ, Wang Y, Jansen JA, Yang F.
Performance of different three-dimensional scaffolds for in
vivo endochondral bone generation. Eur Cell Mater 2014;27:
350e64.
[18] Kim TH, Yun YP, Park YE, Lee SH, Yong W, Kundu J, et al. In
vitro and in vivo evaluation of bone formation using solid
freeform fabrication-based bone morphogenic protein-2
releasing PCL/PLGA scaffolds. Biomed Mater 2014;9:025008.
http://dx.doi.org/10.1088/1748-6041/9/2/025008.
[19] Padalhin AR, Linh NTB, Min YK, Lee BT. Evaluation of the
cytocompatibility hemocompatibility in vivo bone tissue
regenerating capability of different PCL blends. J Biomat Sci
Polym Ed 2014;25:487e503.
[20] Kai H, Wang X, Madhukar KS, Qin L, Yan Y, Zhang R. Fabrica-
tion of a two-level tumor bone repair biomaterial based on a
rapid prototyping technique. Biofabrication 2009;1:025003.
http://dx.doi.org/10.1088/1758-5082/1/2/025003.
[21] Chen SH, Lei M, Xie XH, Zheng LZ, Yao D, Wang XL, et al.
PLGA/TCP composite scaffold incorporating bioactive phyto-
molecule icaritin for enhancement of bone defect repair in
rabbits. Acta Biomater 2013;9:6711e22.
[22] Qin L, Yao D, Zheng LZ, Liu WC, Liu Z, Lei M, et al. Phy-
tomolecule icaritin incorporated PLGA/TCP scaffold for
3D printing for orthopaedic applications 49steroid-associated osteonecrosis: proof-of-concept for pre-
vention of hip joint collapse in bipedal emus and mechanistic
study in quadrupedal rabbits. Biomaterials 2015;59:125e43.
[23] Sugawara T, Higashiyama N, Kaneyama S, Takabatake M,
Watanabe N, Uchida F, et al. Multistep pedicle screw insertion
procedure with patient-specific lamina fit-and-lock templates
for the thoracic spine Clinical article. J Neurosurg Spine 2013;
19:185e90.
[24] Noble JW, Moore CA, Liu N. The value of patient-matched
instrumentation in total knee arthroplasty. J Arthroplasty
2012;27:153e5.
[25] Xu N, Wei F, Liu X, Jiang L, Cai H, Li Z, et al. Reconstruction of
the upper cervical spine using a personalized 3D-printed
vertebral body in an adolescent with Ewing sarcoma. Spine
(Phila Pa 1976) 2015;41:50e4.
[26] Imanishi J, Choong PF. Three-dimensional printed calcaneal
prosthesis following total calcanectomy. Int J Surg Case Rep
2015;10:83e7.
[27] Albrektsson T, Johansson C. Osteoinduction, osteoconduction
and osseointegration. Eur Spine J 2001;10(Suppl. 2):96e101.
[28] Oryan A, Alidadi S, Moshiri A, Maffulli N. Bone regenerative
medicine: classic options, novel strategies, and future di-
rections. J Orthop Surg Res 2014;9:18e45.
[29] Wang X, Schro¨der H, Mu¨ller W. Enzymatically synthesized
inorganic polymers as morphogenetically active bone scaf-
folds: application in regenerative medicine. Int Rev Cell Mol
Biol 2014;313:27e77.
[30] Fedorovich NE, Alblas J, de Wijn JR, Hennink WE, Verbout AJ,
Dhert WJA. Hydrogels as extracellular matrices for skeletal
tissue engineering: state-of-the-art and novel application in
organ printing. Tissue Eng 2007;13:1905e25.
[31] Cui J, Lackey MA, Madkour AE, Saffer EM, Griffin DM,
Bhatia SR, et al. Synthetically simple, highly resilient hydro-
gels. Biomacromolecules 2012;13:584e8.
[32] Bryant SJ, Anseth KS. Hydrogel properties influence ECM
production by chondrocytes photoencapsulated in poly
(ethylene glycol) hydrogels. J Biomed Mater Res 2002;59:
63e72.
[33] Elisseeff J, McIntosh W, Anseth K, Riley S, Ragan P, Langer R.
Photoencapsulation of chondrocytes in poly(ethylene oxide)-
based semi-interpenetrating networks. J Biomed Mater Res
2000;51:164e71.
[34] He HY, Zhang JY, Mi X, Hu Y, Gu XY. Rapid prototyping for
tissue-engineered bone scaffold by 3D printing and biocom-
patibility study. Int J Clin Exp Med 2015;8:11777e85.
[35] Fielding G, Bose S. SiO2 and ZnO dopants in three-dimen-
sionally printed tricalcium phosphate bone tissue engineering
scaffolds enhance osteogenesis and angiogenesis in vivo. Acta
Biomater 2013;9:9137e48.
[36] Gao GF, Schilling AF, Yonezawa T, Wang J, Dai GH, Cui XF.
Bioactive nanoparticles stimulate bone tissue formation in
bioprinted three-dimensional scaffold and human mesen-
chymal stem cells. Biotechnol J 2014;9:1304e11.
[37] Patel M, Patel KJ, Caccamese JF, Coletti DP, Sauk JJ,
Fisher JP. Characterization of cyclic acetal hydroxyapatite
nanocomposites for craniofacial tissue engineering. J Biomed
Mater Res Part A 2010;94:408e18.
[38] Sophia Fox AJ, Bedi A, Rodeo SA. The basic science of articular
cartilage: structure, composition, and function. Sports Health
2009;1:461e9.
[39] Klein TJ, Rizzi SC, Reichert JC, Georgi N, Malda J,
Schuurman W, et al. Strategies for zonal cartilage repair using
hydrogels. Macromol Biosci 2009;9:1049e58.
[40] Fedorovich NE, Schuurman W, Wijnberg HM, Prins HJ, van
Weeren PR, Malda J, et al. Biofabrication of osteochondral
tissue equivalents by printing topologically defined, cell-laden hydrogel scaffolds. Tissue Eng Part C Methods 2012;18:
33e44.
[41] Shim JH, Lee JS, Kim JY, Cho DW. Bioprinting of a mechani-
cally enhanced three-dimensional dual cell-laden construct
for osteochondral tissue engineering using a multi-head tis-
sue/organ building system. J Micromech Microeng 2012;22:
085014. http://dx.doi.org/10.1088/0960-1317/22/8/085014.
[42] Di Bella C, Fosang A, Donati DM, Wallace GG, Choong PFM. 3D
bioprinting of cartilage for orthopedic surgeons: reading be-
tween the lines. Front Surg 2015;2:1e7.
[43] Xu T, Binder KW, Albanna MZ, Dice D, Zhao W, Yoo JJ, et al.
Hybrid printing of mechanically and biologically improved
constructs for cartilage tissue engineering applications. Bio-
fabrication 2013;5:015001. http://dx.doi.org/10.1088/1758-
5082/5/1/015001.
[44] Nguyen LH, Kudva AK, Saxena NS, Roy K. Engineering articular
cartilage with spatially-varying matrix composition and me-
chanical properties from a single stem cell population using a
multi-layered hydrogel. Biomaterials 2011;32:6946e52.
[45] Pati F, Jang J, Ha DH, Kim SW, Rhie JW, Shim JH, et al. Printing
three-dimensional tissue analogues with decellularized
extracellular matrix bioink. Nat Commun 2014;5:3935e46.
[46] Cheung HS. Distribution of type I, II, III and V in the pepsin
solubilized collagens in bovine menisci. Connect Tissue Res
1987;16:343e56.
[47] Buma P, Ramrattan NN, van Tienen TG, Veth RPH. Tissue en-
gineering of the meniscus. Biomaterials 2004;25:1523e32.
[48] Grogan SP, Chung PH, Soman P, Chen P, Lotz MK, Chen SC,
et al. Digital micromirror device projection printing system for
meniscus tissue engineering. Acta Biomater 2013;9:7218e26.
[49] Lee CH, Rodeo SA, Fortier LA, Lu C, Erisken C, Mao JJ. Protein-
releasing polymeric scaffolds induce fibrochondrocytic dif-
ferentiation of endogenous cells for knee meniscus regener-
ation in sheep. Sci Transl Med 2014;6:266ra171. http:
//dx.doi.org/10.1126/scitranslmed.3009696.
[50] Choi JS, Lee SJ, Christ GJ, Atala A, Yoo JJ. The influence of
electrospun aligned poly(epsilon-caprolactone)/collagen
nanofiber meshes on the formation of self-aligned skeletal
muscle myotubes. Biomaterials 2008;29:2899e906.
[51] Merceron TK, Burt M, Seol YJ, Kang HW, Lee SJ, Yoo JJ, et al.
A 3D bioprinted complex structure for engineering the muscle-
tendon unit. Biofabrication 2015;7:035003. http://dx.doi.org/
10.1088/1758-5090/7/3/035003.
[52] Zhang W, He J, Li X, Liu Y, Bian W, Li D, et al. [Fabrication and
in vivo implantation of ligament-bone composite scaffolds
based on three-dimensional printing technique]. Zhongguo Xiu
Fu Chong Jian Wai Ke Za Zhi 2014;28:314e7.
[53] Murphy SV, Atala A. 3D bioprinting of tissues and organs. Nat
Biotechnol 2014;32:773e85.
[54] Pratt J. MedShape announces FDA clearance of new 3D printed
titanium bone tether plate that preserves bone anatomy.




[55] Morrison RJ, Hollister SJ, Niedner MF, Mahani MG, Park AH,
Mehta DK, et al. Mitigation of tracheobronchomalacia with 3D-
printed personalized medical devices in pediatric patients. Sci
Transl Med 2015;7:285ra64. http://dx.doi.org/10.1126/
scitranslmed.aac4749.
[56] FDA. Public Workshopeadditive manufacturing of medical
devices: an interactive discussion on the technical consider-
ations of 3D printing, October 8e9, 2014. MD, USA: Silver
Spring; 2014. Available at: http://www.fda.gov/Medical
Devices/NewsEvents/WorkshopsConferences/ucm397324.htm
[accessed 28.12.15].
